Geron Announces New Imerge Analyses Presented at Ash Suggesting Clinical Activity of Rytelo™ (Imetelstat) in Patients With Lower-Risk Mds Regardless of Type or Number of Prior Therapies
傑龍宣佈在ASH上發佈的新Imerge分析，表明Rytelo™（Imetelstat）在低風險MDS患者中具有臨床活性，與之前治療的類型或數量無關
